Johnson & Johnson (JNJ.DE)

EUR 139.6

(1.09%)

EBITDA Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual EBITDA in 2023 was 23.32 Billion USD , up 34.54% from previous year.
  • Johnson & Johnson's latest quarterly EBITDA in 2024 Q1 was 8.64 Billion USD , up 26.8% from previous quarter.
  • Johnson & Johnson reported an annual EBITDA of 26.6 Billion USD in 2022, down -6.52% from previous year.
  • Johnson & Johnson reported an annual EBITDA of 26.75 Billion USD in 2021, up 26.33% from previous year.
  • Johnson & Johnson reported a quarterly EBITDA of 5.37 Billion USD for 2024 Q3, down -42.06% from previous quarter.
  • Johnson & Johnson reported a quarterly EBITDA of 9.28 Billion USD for 2024 Q2, up 7.32% from previous quarter.

Annual EBITDA Chart of Johnson & Johnson (2023 - 1989)

Historical Annual EBITDA of Johnson & Johnson (2023 - 1989)

Year EBITDA EBITDA Growth
2023 23.32 Billion USD 34.54%
2022 26.6 Billion USD -6.52%
2021 26.75 Billion USD 26.33%
2020 23.92 Billion USD -8.06%
2019 24.65 Billion USD -1.89%
2018 25.93 Billion USD 13.68%
2017 24.24 Billion USD -8.51%
2016 24.28 Billion USD 14.0%
2015 23.49 Billion USD -10.76%
2014 24.99 Billion USD 9.1%
2013 20.05 Billion USD 7.38%
2012 17.97 Billion USD -6.52%
2011 19.46 Billion USD 17.78%
2010 16.52 Billion USD -2.95%
2009 18.98 Billion USD -4.05%
2008 17.74 Billion USD -11.6%
2007 20.07 Billion USD 27.27%
2006 15.88 Billion USD 1.04%
2005 14.92 Billion USD 3.94%
2004 14.48 Billion USD 13.16%
2003 12.74 Billion USD 12.26%
2002 11.34 Billion USD 20.89%
2001 9.49 Billion USD 21.04%
2000 8.2 Billion USD 6.43%
1999 7.49 Billion USD 9.13%
1998 6.31 Billion USD 23.9%
1997 5.68 Billion USD 2.9%
1996 5.31 Billion USD 23.49%
1995 4.36 Billion USD 23.61%
1994 3.53 Billion USD 21.97%
1993 3.01 Billion USD 5.32%
1992 2.83 Billion USD 4.86%
1991 2.65 Billion USD 7.75%
1990 2.46 Billion USD 18.84%
1989 2.07 Billion USD 15.6%

Peer EBITDA Comparison of Johnson & Johnson

Name EBITDA EBITDA Difference
Bayer Aktiengesellschaft 4.2 Billion EUR -454.051%
Sanofi 11.99 Billion EUR -94.382%